NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: D
Post# of 188
(Total Views: 248)
Posted On: 07/24/2020 3:22:33 PM
NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Provides Standout Solution for Digital Diabetes Management
DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, was recently featured in a Data Bridge Market Research report. The piece highlighted DarioHealth’s advancements in digital diabetes management, a rapidly growing market expected to become the “next best thing” in the wake of the current coronavirus pandemic that has made it more difficult for patients to receive treatment. A recent article discussing the company’s standout solution reads, “With 4.9 stars on the Apple App Store and 11,000 reviews, Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario(TM) mobile app is a popular product with over 50,000 consumers around the globe. With a powerful commitment and contribution to chronic condition management through innovative digital-therapeutic solutions, including a novel method for chronic-disease data management, the company is rapidly moving toward addressing new chronic conditions and into new geographic markets.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, was recently featured in a Data Bridge Market Research report. The piece highlighted DarioHealth’s advancements in digital diabetes management, a rapidly growing market expected to become the “next best thing” in the wake of the current coronavirus pandemic that has made it more difficult for patients to receive treatment. A recent article discussing the company’s standout solution reads, “With 4.9 stars on the Apple App Store and 11,000 reviews, Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario(TM) mobile app is a popular product with over 50,000 consumers around the globe. With a powerful commitment and contribution to chronic condition management through innovative digital-therapeutic solutions, including a novel method for chronic-disease data management, the company is rapidly moving toward addressing new chronic conditions and into new geographic markets.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)DarioHealth Corp. (DRIO) Stock Research Links
Scroll down for more posts ▼